Cargando…
Studies of the pharmacokinetic properties of nimorazole.
The pharmacokinetics of the hypoxic radio-sensitizer nimorazole were studied in 19 individuals after single oral doses of between 0.5-3.5 g. HPLC measurements showed, after a rapid absorption, a linear relationship between peak plasma concentration and given dose. Mean elimination half life was 3.1...
Autores principales: | Overgaard, J., Overgaard, M., Timothy, A. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011427/ https://www.ncbi.nlm.nih.gov/pubmed/6871077 |
Ejemplares similares
-
A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
por: Overgaard, J., et al.
Publicado: (1982) -
Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
por: Koi, Lydia, et al.
Publicado: (2023) -
Low-energy electrons transform the nimorazole molecule into a radiosensitiser
por: Meißner, Rebecca, et al.
Publicado: (2019) -
Bound Electron Enhanced Radiosensitisation of Nimorazole upon Charge Transfer
por: Kumar, Sarvesh, et al.
Publicado: (2022) -
3-D microarchitectural properties and rod- and plate-like trabecular morphometric properties of femur head cancellous bones in patients with rheumatoid arthritis, osteoarthritis, and osteoporosis
por: Ding, Ming, et al.
Publicado: (2021)